Half-year Results
Red Capital reports H1 2025 loss of £99,548 with cash balance declining to £40,765 from £160,427.
- Loss after taxation £99,548 (prior £110,517)
- Cash and cash equivalents £40,765 (prior £160,427)
- Loss per share £0.01 (prior £0.01)
- Operating expenses £99,802 (prior £111,803)
- Total net assets £23,965 (prior £122,729)
Select text to share a quote on X · sign in to keep highlights & notes in your VZLA notes
Red Capital Plc (LSE: REDC, "Red" or the "Company") announces its unaudited condensed interim results for the six month period to 30 June 2025.
Strategy
Red was established in 2021 to undertake one or more investment and / or acquisition opportunities of businesses operating within the UK or internationally across certain sectors.
The Company retains a flexible investment and acquisition strategy which will, subject to appropriate levels of due diligence, enable it to deploy capital in target companies by way of minority or majority investments, or full acquisitions where it is in the interests of shareholders to do so.
The Company's strategic aim is to drive shareholder value through the acquisition of target companies in certain sectors where the Board believes there to be sustainable growth opportunities both organically, and through acquisition. Sectors of particular focus include business services and technology.
The Company is the parent company of Red Capital Subco Limited (a private limited company under the laws of Jersey with registered number 134741) and together will be referred to as the "Group" in these accounts.
Results and developments in the six month period to 30 June 2025
The Group's loss after taxation was £99,548 (six month period to 30 June 2024: loss of £110,517). This principally reflected operating expenses incurred as a listed business of £99,802 (six month period to 30 June 2024: £111,803).
The Group generated a loss per share of £0.01 (six month period to 30 June 2024: loss per share of £0.01).
As a result of tight cost control and moderate operating expenses, as at 30 June 2025, Red's cash balance was £40,765 (31 December 2024: £160,427).
On 18 June 2025, the Company held its Annual General Meeting in which all resolutions were unanimously passed.
Risks
As the Company has yet to complete an investment or acquisition, it has limited financial statements and / or historical financial data, and limited trading history. As such, the Group and Company during the period were subject to the risks and uncertainties associated with an early-stage acquisition company.
The Directors are of the opinion that these risks, which were detailed further in Red's published final results for the financial year ended 31 December 2024, remain applicable to the Group and Company.
Dividend
At this point in the Company's development, it does not anticipate declaring any dividends in the foreseeable future. Following the Company's inaugural investment or acquisition, the Directors will determine an appropriate dividend policy for Red.
Outlook
During the period, and post period end, Red has continued to pursue its investment and acquisition strategy and is currently assessing opportunities within its chosen sectors of interest. These include successful businesses with the potential for high growth that are seeking to partner with, and leverage the benefits of, the Board's experience and that of the wider Red team. The Directors look forward to updating shareholders in due course.
Statement of Directors' responsibilities
By order of the Board
David Williams
Chairman
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 June 2025
| Note | As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
|---|---|---|---|
| Current assets | |||
| Cash and cash equivalents | 7 | 40,765 | 160,427 |
| Trade and other receivables | 8 | 16,029 | 7,102 |
| Total current assets | 56,794 | 167,529 | |
| Total assets | 56,794 | 167,529 | |
| Current liabilities | |||
| Trade and other payables | 9 | 32,829 | 44,800 |
| Total current liabilities | 32,829 | 44,800 | |
| Total liabilities | 32,829 | 44,800 | |
| Total net assets | 23,965 | 122,729 | |
| Equity | |||
| Share capital | 12 | 100,000 | 100,000 |
| Share premium | 13 | 894,998 | 894,998 |
| Capital redemption reserve | 13 | 2 | 2 |
| Share-based payment reserve | 13 | 5,697 | 4,913 |
| Retained deficit | 13 | (976,732) | (877,184) |
| Total equity attributable to equity holders of the Company | 23,965 | 122,729 | |
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the six months ended 30 June 2024 (Unaudited)
| Share capital £ | Share premium £ | Capital redemption reserve £ | Share-based payment reserve £ | Retained deficit £ | Total Equity £ | |
|---|---|---|---|---|---|---|
| Balance as at 31 December 2023 | 100,000 | 894,998 | 2 | 3,344 | (643,534) | 354,810 |
| Loss for the period | - | - | - | - | (110,517) | (110,517) |
| Share-based payment charge | - | - | - | 784 | - | 784 |
| Balance as at 30 June 2024 | 100,000 | 894,998 | 2 | 4,128 | (754,051) | 245,077 |
| For the six months ended 30 June 2025 (Unaudited) | ||||||
| Share capital £ | Share premium £ | Capital redemption reserve £ | Share-based payment reserve £ | Retained deficit £ | Total Equity £ | |
| Balance as at 31 December 2024 | 100,000 | 894,998 | 2 | 4,913 | (877,184) | 122,729 |
| Loss for the period | - | - | - | - | (99,548) | (99,548) |
| Share-based payment charge | - | - | - | 784 | - | 784 |
| Balance as at 30 June 2025 | 100,000 | 894,998 | 2 | 5,697 | (976,732) | 23,965 |
The accompanying notes form part of these interim condensed consolidated financial statements.
INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
For the six months ended 30 June 2025
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | |
|---|---|---|
| Cash flows from operating activities | ||
| Loss before income tax | (99,548) | (110,517) |
| Adjustments for: | ||
| Share-based payment charge | 784 | 784 |
| Interest receivable | (254) | (1,286) |
| Operating cash flows before changes in working capital | (99,018) | (111,019) |
| Increase in trade and other receivables | (9,132) | (88) |
| Decrease in trade and other payables | (11,971) | (23,949) |
| Net cash used in operating activities | (120,121) | (135,056) |
| Interest received | 459 | 1,509 |
| Net cash inflow from financing activities | 459 | 1,509 |
| Net decrease in cash and cash equivalents | (119,662) | (133,547) |
| Cash and cash equivalents at beginning of period | 160,427 | 399,766 |
| Cash and cash equivalents at end of period | 40,765 | 266,219 |
As the Group does not have any financing liabilities outside of working capital and has no cashflows from financing activities in both periods presented, no separate net debt reconciliation has been presented within these interim condensed consolidated financial statements.
The accompanying notes form part of these interim condensed consolidated financial statements.
NOTES TO THE GROUP FINANCIAL INFORMATION
For the six months ended 30 June 2025
General information
The address of its registered office is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey.
Basis of preparation
Comparative figures
Statutory accounts
Going concern
The Directors, having made due and careful enquiry, are of the opinion that the Group and Company have adequate working capital to execute their operations over the next 12 months ("the going concern period"). The Group and Company's unaudited cash balance as at 18 September 2025 was £207. Excluding the consummation of any investment or acquisition which will likely require specific funding, the Group and Company have adequate resources available to it to fund the on-going forecast operating expenses during the going concern period as a result of an undertaking of the provision of financial support provided by the Directors to the Group, and by other shareholders of the Company. The Directors, therefore, have made an informed judgement at the time of approving the interim condensed consolidated financial statements, that there is a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future. As a result, the Directors have adopted the going concern basis of accounting in preparing the interim condensed consolidated financial statements.
Significant accounting policies
Basis of consolidation
Functional and presentational currency
Interest receivable
Employee benefits
Taxation
Tax on the profit or loss for the period comprises current and deferred tax. Tax is recognised in the income statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case it is recognised in other comprehensive income or equity respectively.
Cash and cash equivalents
Financial assets and liabilities
Equity
Share capital is measured at the par value.
Share-based payment reserve includes the cumulative share-based payment charged to equity.
Share-based payments
Warrants
Warrants issued as part of share issues have been determined as equity instruments under IAS 32. Since the fair value of the shares issued at the same time as the warrants is equal to the price paid, these warrants, by deduction, are considered to have been issued at fair value. No warrants have been exercised in the period or recognised in these interim consolidated financial statements. For further details of the warrants issued please refer to the Group's latest annual report at 31 December 2024.
Related party transactions
Standards in issue but not yet effective
- Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial Instruments (effective for annual periods beginning on or after 1 January 2026)
- IFRS 18 Presentation and Disclosure in Financial Statements (effective for annual periods beginning on or after 1 January 2027
- IFRS 19 Subsidiaries without Public Accountability: Disclosures (effective for annual periods beginning on or after 1 January 2027)
Critical accounting estimates and judgments
In preparing the interim condensed consolidated financial statements, the Directors have to make judgments on how to apply the Group's accounting policies and make estimates about the future. The Directors do not consider there to be any critical judgments that have been made in arriving at the amounts recognised in the interim condensed consolidated financial statements with the exception of the valuation of share-based payments. Please see Note 15 for further details.
Interest receivable
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | |||
|---|---|---|---|---|
| Bank interest receivable | 254 | 1,286 | ||
| 6. Investments | ||||
| Principal subsidiary undertakings of the Group | ||||
| Subsidiary | Nature of business | Country of incorporation | Proportion of A ordinary shares held by Company | Proportion of B ordinary shares held by Company |
| Red Capital Subco Limited | Intermediate holding company | Jersey, Channel Islands | 100 per cent. | 0 per cent. |
The address of the registered office of Red Capital Subco Limited (the "Subco") is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey. The Subco was incorporated on 31 March 2021 and prepares its own financial statements for the period ended 31 December each year.
Cash and cash equivalents
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
|---|---|---|
| Cash at bank and in hand | 40,765 | 160,427 |
| 8. Trade and other receivables | ||
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
| Other receivables | 82 | 287 |
| Prepayments | 15,947 | 6,815 |
| Total | 16,029 | 7,102 |
| 9. Trade and other payables | ||
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
| Accruals | 32,829 | 44,800 |
| Total | 32,829 | 44,800 |
| 10. Earnings per share | ||
| Six months ended 30 June 2025 Unaudited £ | Six months ended 30 June 2024 Unaudited £ | |
| Loss attributable to the equity holders of the Company | (99,548) | (110,517) |
| Adjustments: | ||
| Share-based payment charge | 784 | 784 |
| Adjusted earnings used in adjusted EPS | (98,764) | (109,733) |
| Weighted number of shares in issue | 10,000,000 | 10,000,000 |
| Loss per share(£) | ||
| Basic and diluted | (0.01) | (0.01) |
| Adjusted - basic and diluted | (0.01) | (0.01) |
| 11. Financial instruments | ||
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
| Financial assets | ||
| Cash and cash equivalents | 40,765 | 160,427 |
| Other receivables | 82 | 287 |
| Total | 40,847 | 160,714 |
| As at 30 June 2025 Unaudited £ | As at 31 December 2024 Audited £ | |
| Financial liabilities | ||
| Accruals | 32,829 | 44,800 |
Financial risk management objectives and policies
The Group's financial assets and liabilities comprise of cash and cash equivalents, other receivables and accruals. The carrying value of all financial assets and liabilities equals fair value given their short-term nature.
Credit risk
Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due. The Group's approach to liquidity risk is to ensure that sufficient liquidity is available to meet foreseeable requirements and to invest funds securely and profitably.
Share capital
Allocated, called up and fully paid
| As at 30 June 2025 Unaudited | As at 30 June 2025 Unaudited | As at 31 December 2024 Audited | As at 31 December 2024 Audited | |
|---|---|---|---|---|
| Number | £ | Number | £ | |
| Ordinary shares of 1p each | 10,000,000 | 100,000 | 10,000,000 | 100,000 |
Reserves
Share-based payment reserve includes the cumulative share-based payment charged to equity.
The Group having no regulatory or similar requirements, its primary capital management focus is on maximising earnings per share and therefore shareholder return.
- Share incentive plan
- Share-based payments
These conditions include good and bad leaver provisions and that growth in Shareholder Value of 12.5 per cent. compound per annual is delivered over a three to five year period for the scheme to vest. This second condition is therefore a market condition which has been taken into account in the measurement at grant date of the fair value of the options.
The B share options have a weighted average contractual life of 1 years 4 months. No B share options were issued in the six months ended 30 June 2025 and all B share options remained outstanding at the period end. No B share options were exercised in the period. No B share options have expired during the period. The weighted average exercise price of the outstanding 110,000 B share options is £Nil.
The Group recognised £784 (six months ended 30 June 2024: £784) of expenditure in the statement of total comprehensive income in relation to equity-settled share-based payments in the period.
The inputs into the binomial model in respect of options granted in the period are as follows:
| Opening share price | 10.0p |
| Expected volatility of share price | 16.67% |
| Expected life of options | 5 years |
| Risk-free rate | 0.92% |
| Target increase in share price per annum | 12.5% |
| Fair value of options | 7.152p |
Related party transactions
Transactions with key management personnel
Key management personnel comprise the directors. The total emoluments for key management personnel in the period was £25,000 (six months ended 30 June 2024: £25,000).
Other transactions
There are no related party transactions noted in the period.
- Contingent liabilities
- Events after the reporting date
- Ultimate controlling party
In the opinion of the Directors, there is no single ultimate controlling party.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.